Bhutan vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Bhutan
100.0%
in 2024
Oman
100.0%
in 2024
Bhutan rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bhutan
- Oman
How they compare
Bhutan currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2008 it was Oman ahead.
Bhutan ranks 1st and Oman ranks 1st of 144 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 92.9% | 91.9% | 1.0% | Bhutan |
| 2020s | 100.0% | 91.4% | 8.6% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bhutan or Oman?
- Bhutan, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bhutan and Oman?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Oman?
- 14 years are reported by both, from 2008 to 2024.
- How do Bhutan and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bhutan ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.